ISB News

Former Undergrad Intern Publishes Algorithm in PLOS Computational Biology

William Poole, 2013 undergrad intern

Posted March 1, 2017

In a study published in PLoS Computational Biology, researchers at Institute for Systems Biology (ISB) have developed a multiscale mutation clustering algorithm (M2C) that identifies variable length regions with high mutation density in cancer genes. The M2C algorithm was developed by William Poole (first author on the paper), who started as a summer intern in 2013 as part of ISB’s Center for Systems Biology internship program. Working under the guidance of Dr. Brady Bernard and Dr. Theo Knijnenburg, both senior research scientists in the lab of Ilya Shmulevich at ISB, Poole’s initial summer internship led to a multi-year project that resulted not only in this PLoS Computational Biology publication, but also a Bioinformatics publication about combining dependent P-values. His work was presented at two international scientific conferences: the TCGA Scientific Symposium 2015 and The 15th European Conference on Computational Biology (ECCB 2016). Currently, Poole is pursuing a PhD at the California Institute of Technology (Caltech) in Pasadena, California.

READ FULL SUMMARY OF PAPER

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.